| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907432 | Experimental Hematology | 2011 | 9 Pages |
Abstract
ECP is cytotoxic for HL tumor cells even at low concentrations, but heterogeneity between cell lines exists and not all tumor cells are eradicated. Two cell lines of B-cell origin, KMH2 and L428, were sensitive to ECP in a doseâresponse manner, but for HDLM-2, which is of T-cell origin, the cytotoxicity reached a plateau.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ingrid Glimelius, Jenny Rubin, Marie Fischer, Daniel Molin, Rose-Marie Amini, Per Venge, Gunilla Enblad,